These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 17479711)

  • 1. Cardiovascular risk factors: hemorheologic and hemostatic components.
    Martins e Silva J; Saldanha C
    Rev Port Cardiol; 2007 Feb; 26(2):161-82. PubMed ID: 17479711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemostatic factors and risk of cardiovascular disease in women. An overview.
    Meilahn EN
    Arch Pathol Lab Med; 1992 Dec; 116(12):1313-7. PubMed ID: 1456877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemostatic and rheological variables and risk of cardiovascular disease.
    Lowe GD; Rumley A; Whincup PH; Danesh J
    Semin Vasc Med; 2002 Nov; 2(4):429-39. PubMed ID: 16222632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Global risk and objectives in cardiovascular diseases].
    Güleç S
    Turk Kardiyol Dern Ars; 2009 Mar; 37 Suppl 2():1-10. PubMed ID: 19404044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Updating the assessment of cardiac risk: beyond Framingham.
    Borden WB; Davidson MH
    Rev Cardiovasc Med; 2009; 10(2):63-71. PubMed ID: 19593318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chronic renal disease as cardiovascular risk factor].
    Hermans MM; Kooman JP; Stehouwer CD
    Ned Tijdschr Geneeskd; 2008 Jul; 152(29):1614-8. PubMed ID: 18998268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of a multiple biomarkers strategy including endothelial dysfunction to improve risk stratification for cardiovascular events in patients at high risk for coronary heart disease.
    Nozaki T; Sugiyama S; Koga H; Sugamura K; Ohba K; Matsuzawa Y; Sumida H; Matsui K; Jinnouchi H; Ogawa H
    J Am Coll Cardiol; 2009 Aug; 54(7):601-8. PubMed ID: 19660689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular disease risk factors in polycystic ovary syndrome.
    Dokras A
    Semin Reprod Med; 2008 Jan; 26(1):39-44. PubMed ID: 18181081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prevalence of cardiovascular disease risk factors in patients from Croatian Zagorje County treated at Department of Medicine, Zabok General Hospital from 2000 to 2006.
    Pesek K; Pesek T; Rados M; Buković D; Fures R; Cuk V
    Coll Antropol; 2007 Sep; 31(3):709-15. PubMed ID: 18041378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are traditional risk factors valid for assessing cardiovascular risk in end-stage renal failure patients?
    Shah DS; Polkinghorne KR; Pellicano R; Kerr PG
    Nephrology (Carlton); 2008 Dec; 13(8):667-71. PubMed ID: 18761627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of three different methods of assessing cardiovascular disease risk in New Zealanders with Type 2 diabetes mellitus.
    Metcalf PA; Wells S; Scragg RK; Jackson R
    N Z Med J; 2008 Sep; 121(1281):49-57. PubMed ID: 18797484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screen detection and the WHO stepwise approach to the prevalence and risk factors of arterial hypertension in Kinshasa.
    Longo-Mbenza B; Ngoma DV; Nahimana D; Mayuku DM; Fuele SM; Ekwanzala F; Beya C
    Eur J Cardiovasc Prev Rehabil; 2008 Oct; 15(5):503-8. PubMed ID: 18830083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anthropometric measures and absolute cardiovascular risk estimates in the Australian Diabetes, Obesity and Lifestyle (AusDiab) Study.
    Chen L; Peeters A; Magliano DJ; Shaw JE; Welborn TA; Wolfe R; Zimmet PZ; Tonkin AM
    Eur J Cardiovasc Prev Rehabil; 2007 Dec; 14(6):740-5. PubMed ID: 18043293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kidney transplantation candidates and cardiovascular risk factors.
    Noshad H; Ardalan MR; Mortazavi M; Tayebi H; Safa J; Nezami N
    Transplant Proc; 2007 May; 39(4):871-4. PubMed ID: 17524836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cardiovascular risk profile in a Portuguese cohort of SLE Portuguese patients].
    Duarte C; Couto M; Vaz C; Inês L; Malcata A
    Acta Reumatol Port; 2009; 34(2B):349-57. PubMed ID: 19727047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronary heart disease and cardiovascular risk factors among people aged 25-65 years, as seen in Romanian primary healthcare.
    Bunescu DM; Stoffers HE; van den Akker M; Jan Dinant G
    Eur J Gen Pract; 2008; 14(2):56-64. PubMed ID: 18720274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are biomarkers useful for assessing cardiovascular risk in patients with chronic kidney disease?
    Rubin C; Nolin TD; Himmelfarb J
    Curr Opin Nephrol Hypertens; 2007 Nov; 16(6):506-11. PubMed ID: 18089962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Body-mass index, waist-size, waist-hip ratio and cardiovascular risk factors in urban subejcts.
    Gupta R; Rastogi P; Sarna M; Gupta VP; Sharma SK; Kothari K
    J Assoc Physicians India; 2007 Sep; 55():621-7. PubMed ID: 18051732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of undiagnosed Type-2-diabetes mellitus and impaired fasting glucose in German primary care: data from the German Metabolic and Cardiovascular Risk Project (GEMCAS).
    Hauner H; Hanisch J; Bramlage P; Steinhagen-Thiessen E; Schunkert H; Jöckel KH; Wasem J; Moebus S
    Exp Clin Endocrinol Diabetes; 2008 Jan; 116(1):18-25. PubMed ID: 17926235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Etiopathogenesis of cardiovascular disease: hemostasis, thrombosis, and vascular medicine.
    Lowe GD
    Ann Periodontol; 1998 Jul; 3(1):121-6. PubMed ID: 9722696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.